Project Details
Projekt Print View

Mechanisms of protective versus autoreactive B cells in systemic lupus erythematosus

Subject Area Rheumatology
Term from 2008 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 74975068
 
Final Report Year 2025

Final Report Abstract

This grant was able to successfully delineate certain characteristics of a defined antiviral protective immune response (mainly anti-RBD of SARS-Cov2 versus tetanus/TT) given that the SARS-Cov2 pandemia dominated largely the project start in 2020. After initial establishment of reliable assays to detect B lineage as well as T cell responses, we identified important variables for successful protective anti-RBD responses (disease: rheumatoid arthritis, dialysis, kidney transplantation; treatment: immunosuppressive agents, B cell depletion/rituximab) beyond conventional factors. In the normal human bone marrow, we originally identified hitherto unknown 10 plasma cell (PC) clans with a distinct cytokine signature including IL-21 dependent fraction of CD19- long-lived PC with enrichment of longerlive tetanus-specific BMPC. Additional BMPC studies evaluated the co-expression of CD56 on CD19low and CD19- BMPC. Here, CD19-CD56+ BMPC did not contain RBD specific clones while enriched for TT-specific BMPC. On the transcriptional level, NCAM-1+(encodes CD56)/CD19- BMPC carried a transcriptional profile of longevity and intense cell-cell interaction mandating ongoing studies in autoimmunity. Another critical observation was the requirement of 10 B cells/ul for proper IgG induction as well as activation of CD4 T cells as well as the description of CD19low/CXCR5- pre-plasmablasts. Such cells share functionally characteristics of BCR hyporesponsive memory B cells (anergic post-activated/exhausted) but able to respond to TLR 7/8 as well as via CD40 to T cell signals. The convergence of innate and adaptive immune signalling in particular by antigen-experienced memory B cells requires consideration as treatment targets. Related to the initial grant hypothesis if systemic autoimmune responses follow principles of a conventional primary or secondary immune response, the aggregate of available data suggest that the abnormalities of autoimmune B cell responses do not simply follow primary or secondary responses (i.e. against TT) but more closely following principles of an antiviral response. These results have implications for the deeper understanding of different responses by B and plasma cells, which appear to be clearly determined by the properties of the inciting antigens as well as the underlying T cell activation.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung